Divergence of TGFβ Signaling in Activated Hepatic Stellate Cells Downstream from Smad2 Phosphorylation

Frank Berg,Bert Delvoux,Chunfang Gao,Jens H. Westhoff,Katja Breitkopf,Axel M. Gressner,Steven Dooley

DOI: https://doi.org/10.1002/1615-4061(200205)2:1/2<11::aid-sita11>3.0.co;2-k

2002-01-01

Signal Transduction

Abstract:Transforming growth factor β (TGFβ) is a multifunctional cytokine, that regulates cell proliferation, differentiation, and extracellular matrix production. A profibrogenic role of TGFβ is postulated, but pathways targeting the TGFβ response to specific gene activities involved in phenotypic changes of hepatic stellate cells (HSC) have not been characterized in detail. We investigated TGFβ1-responsiveness of activated HSC and determined Smad2 as intracellular mediator. Gene expression and reporter gene analysis showed, that TGFβ1 treatment lead to upregulation of plasminogen activator inhibitor (PAI-1), Smad7 and (CAGA)9-MLP-Luc subsequent to Smad2 phosphorylation. Two further TGFβ responsive genes, the tissue inhibitor of metalloproteinases 1 and type I collagen were not affected. In contrast to primary cultured HSC, which were inhibited in their growth, TGFβ1 did not influence the proliferation rate of HSC-T6 and CFSC, two permanent cell lines, which both resemble phenotypes of activated HSC. Ectopic expression of Smad7 was able to inhibit TGFβ-dependent Smad2 phosphorylation and stimulation of (CAGA)9-MLP-Luc, but had no effect on collagen expression. Surprisingly, Smad7 did not block TGFβ dependent stimulation of PAI-1 expression or p3TPluc activation in these cells. Furthermore, both HSC-lines displayed constitutively phosphorylated Smad3, whose origin remains to be determined and functional relevance is discussed. We conclude, that regulation of TGFβ actions in activated HSC is complex and involves multiple signaling pathways. Depending on the target gene, different signal transducers and factors may be involved and, therefore, TGFβ-based therapies have to be carefully tailored.